Core Viewpoint - The company, Kewei Medical, is strategically investing in the brain-computer interface sector to enhance its existing business and prepare for future technological integration and industry upgrades [2] Group 1: Strategic Investments - In May 2024, the company will invest in Newlink Medical, acquiring a 5.83% stake, focusing on implantable brain-computer interface technology, particularly in developing bionic eye and ear products [2] - By the end of 2025, the company plans to invest in Lizi Intelligent, holding a 12.45% stake, which is dedicated to non-invasive brain-computer interface robotics [2] Group 2: Business Synergy - The investment in Newlink Medical aligns with the company's existing hearing business, providing significant value in addressing congenital hearing loss [2] - The collaboration with Lizi Intelligent is expected to create strategic synergies with the company's rehabilitation aids and respiratory support products [2] Group 3: Future Outlook - These strategic moves not only strengthen the potential for synergy within the current business but also lay the groundwork for future technological convergence and industry upgrades [2]
可孚医疗：目前公司在脑机接口领域已参与两项战略性投资